Stanie Gaete
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stanie Gaete has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Jacqueline Deloumeaux
Biological Resources Center Karubiotec™ BRIF n° KARUBIOTEC-GUA00971, University Hospital of Guadeloupe, Pointe-à-Pitre, Guadeloupe
4 shared publications - Benoit Tressieres
Caribbean Clinical Investigation Center, Inserm CIC 2504, University Hospital of Guadeloupe, Pointe-À-Pitre/Abymes, France
3 shared publications - Bruno Hoen
Université de Lorraine, Inserm, INSPIIRE, Nancy, France
3 shared publications - Clarisse Joachim
Registre General des Cancers de la Martinique, UF 1441, Pôle de Cancérologie-Hématologie-Urologie, Centre Hospitalier Universitaire de la Martinique, Fort-de-France, France
3 shared publications - Danièle Luce
Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-97100, Pointe-à-Pitre
3 shared publications Anna Louise Funk
Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France
2 shared publications
Latest Publications
- 2 September 2026
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 133 (9) , 2661-2670
Higher serum uric acid associates with better cognitive performance and survival in Caribbean parkinsonism
- 2 September 2026
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 133 (9) , 2661-2670
Higher serum uric acid associates with better cognitive performance and survival in Caribbean parkinsonism
- Open Access
- 6 August 2026
- Published by Elsevier in SSRN Electronic Journal
Chlordécone and other organochlorines and risk of Multiple myeloma and non-Hodgkin Lymphoma: a case-control study in the French West Indies
Background: Guadeloupe and Martinique have experienced chronic chlordecone contamination from banana plantation use (1972–1993), with >90% of adults showing detectable blood levels. Both islands report higher multiple myeloma incidence than mainland France. Epidemiological studies have linked organochlorines to multiple myeloma and non-Hodgkin lymphoma, but no study has examined these associations in the French West Indies.Methods: We conducted a population-based case-control study in Guadeloupe and Martinique. Incident cases of multiple myeloma (n=148) and non-Hodgkin lymphoma (n=44) were recruited through oncology units of the main hospital facilities. Controls (n=363) were selected from the general population by random-digit telephone survey. Blood samples were analyzed for organochlorine concentrations by high-resolution gas chromatography–mass spectrometry. Odds ratios were estimated by unconditional logistic regression with 95% confidence intervals.Results: After multivariable adjustment, serum PCB-153 was positively associated with multiple myeloma and non-Hodgkin lymphoma risk (adjusted OR=1.58, 95% CI: 1.23–2.16, p<0.001) and work in construction sector conferred a 2.47-fold excess risk (OR=2.47, 95% CI: 1.37–4.34, p=0.001). For chlordecone modeled continuously, a borderline inverse association was observed (OR=0.88, 95% CI: 0.75-0.99 p=0.075).Conclusions: These results, from the first organochlorines biomonitoring study linked to multiple myeloma and non-Hodgkin lymphoma in the French West Indies, show no association with chlordecone but provide strong evidence of a PCB-associated cancer risk and identify work in construction sector as an independent risk factor warranting further investigation.
- 6 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessChlordécone and other organochlorines and risk of Multiple myeloma and non-Hodgkin Lymphoma: a case-control study in the French West Indies
Background: Guadeloupe and Martinique have experienced chronic chlordecone contamination from banana plantation use (1972–1993), with >90% of adults showing detectable blood levels. Both islands report higher multiple myeloma incidence than mainland France. Epidemiological studies have linked organochlorines to multiple myeloma and non-Hodgkin lymphoma, but no study has examined these associations in the French West Indies.Methods: We conducted a population-based case-control study in Guadeloupe and Martinique. Incident cases of multiple myeloma (n=148) and non-Hodgkin lymphoma (n=44) were recruited through oncology units of the main hospital facilities. Controls (n=363) were selected from the general population by random-digit telephone survey. Blood samples were analyzed for organochlorine concentrations by high-resolution gas chromatography–mass spectrometry. Odds ratios were estimated by unconditional logistic regression with 95% confidence intervals.Results: After multivariable adjustment, serum PCB-153 was positively associated with multiple myeloma and non-Hodgkin lymphoma risk (adjusted OR=1.58, 95% CI: 1.23–2.16, p<0.001) and work in construction sector conferred a 2.47-fold excess risk (OR=2.47, 95% CI: 1.37–4.34, p=0.001). For chlordecone modeled continuously, a borderline inverse association was observed (OR=0.88, 95% CI: 0.75-0.99 p=0.075).Conclusions: These results, from the first organochlorines biomonitoring study linked to multiple myeloma and non-Hodgkin lymphoma in the French West Indies, show no association with chlordecone but provide strong evidence of a PCB-associated cancer risk and identify work in construction sector as an independent risk factor warranting further investigation.
- Open Access
Antagonistic regulation of HBZ splicing by hnRNPA1 and hnRNPH1 drives HTLV-1 leukemogenesis
Adult T-cell leukemia/lymphoma (ATL) is a highly aggressive leukemia driven by Human T-cell Leukemia Virus type 1 (HTLV-1) and remains largely refractory to current therapies. Although hbz is the only viral transcript consistently expressed in acute ATL, the extent to which its alternative splicing shapes disease biology remains unknown. Here, we demonstrate that the splicing of hbz plays a key role in driving cancer development in ATL. Quantitative analyses in HTLV-1-infected cell lines and primary samples revealed a striking enrichment of the spliced isoform HBZ_SP1 (over 200-fold) in CD4⁺ T cells from ATL patients, whereas the unspliced transcript (usHBZ) predominates in CD8⁺ T cells. Despite robust transcription, the usHBZ protein was undetectable, whereas HBZ_SP1 accumulated rapidly, identifying it as the main isoform in CD4⁺ T cells from ATL patients. Furthermore, only HBZ_SP1 drove cellular transformation and conferred marked resistance to chemotherapeutic stress. Mechanistically, we identify a splicing regulatory axis centered on hnRNPA1 and hnRNPH1. Both proteins bind hbz pre-mRNA, but exert opposing effects: hnRNPA1 represses splicing, whereas hnRNPH1 promotes production of the oncogenic HBZ_SP1 isoform. Perturbation of this balance reprograms HBZ isoform expression and alters leukemic cell fitness. Collectively, our findings establish that HBZ inhibits hnRNPA1 transcription, therefore allowing HTLV-1 to hijack host RNA splicing and to generate an oncogenic isoform that drives transformation and chemoresistance. These results uncover a previously unrecognized post-transcriptional mechanism of viral leukemogenesis and position HBZ splicing and its regulators as therapeutic targets in ATL. Graphical Mechanistic model of HBZ splicing regulation. This simplified graphical abstract summarizes the highlights of our study. Here, we hypothesize that in CD4 + T cells infected by HTLV-1, transcription and splicing reprogramming lead to a preferential expression of the HBZ_SP1 oncogenic isoform, specifically due to an overexpression of the splicing activator hnRNP H1and repression of hnRNP A1 by HBZ itself via C/EBPα. HBZ_SP1 is consistently expressed and then drives cell transformation and chemoresistance. In contrast, in CD8 + T cells infected with HTLV-1, the HBZ-mediated downregulation of hnRNP A1 is overcome, leading to inhibition of HBZ splicing and increased expression of the less oncogenic isoform usHBZ.
Open AccessAntagonistic regulation of HBZ splicing by hnRNPA1 and hnRNPH1 drives HTLV-1 leukemogenesis
Adult T-cell leukemia/lymphoma (ATL) is a highly aggressive leukemia driven by Human T-cell Leukemia Virus type 1 (HTLV-1) and remains largely refractory to current therapies. Although hbz is the only viral transcript consistently expressed in acute ATL, the extent to which its alternative splicing shapes disease biology remains unknown. Here, we demonstrate that the splicing of hbz plays a key role in driving cancer development in ATL. Quantitative analyses in HTLV-1-infected cell lines and primary samples revealed a striking enrichment of the spliced isoform HBZ_SP1 (over 200-fold) in CD4⁺ T cells from ATL patients, whereas the unspliced transcript (usHBZ) predominates in CD8⁺ T cells. Despite robust transcription, the usHBZ protein was undetectable, whereas HBZ_SP1 accumulated rapidly, identifying it as the main isoform in CD4⁺ T cells from ATL patients. Furthermore, only HBZ_SP1 drove cellular transformation and conferred marked resistance to chemotherapeutic stress. Mechanistically, we identify a splicing regulatory axis centered on hnRNPA1 and hnRNPH1. Both proteins bind hbz pre-mRNA, but exert opposing effects: hnRNPA1 represses splicing, whereas hnRNPH1 promotes production of the oncogenic HBZ_SP1 isoform. Perturbation of this balance reprograms HBZ isoform expression and alters leukemic cell fitness. Collectively, our findings establish that HBZ inhibits hnRNPA1 transcription, therefore allowing HTLV-1 to hijack host RNA splicing and to generate an oncogenic isoform that drives transformation and chemoresistance. These results uncover a previously unrecognized post-transcriptional mechanism of viral leukemogenesis and position HBZ splicing and its regulators as therapeutic targets in ATL. Graphical Mechanistic model of HBZ splicing regulation. This simplified graphical abstract summarizes the highlights of our study. Here, we hypothesize that in CD4 + T cells infected by HTLV-1, transcription and splicing reprogramming lead to a preferential expression of the HBZ_SP1 oncogenic isoform, specifically due to an overexpression of the splicing activator hnRNP H1and repression of hnRNP A1 by HBZ itself via C/EBPα. HBZ_SP1 is consistently expressed and then drives cell transformation and chemoresistance. In contrast, in CD8 + T cells infected with HTLV-1, the HBZ-mediated downregulation of hnRNP A1 is overcome, leading to inhibition of HBZ splicing and increased expression of the less oncogenic isoform usHBZ.
- Open Access
Relationship Between Apolipoprotein E Genotypes, Unhealthy Weight Status, and Cognitive Impairment in Older Adults of Predominantly African Descent
Background: Apolipoprotein E4 (APOE4) represents a major genetic risk factor for Alzheimer’s disease. Objectives: We aimed to analyze the relationship between cognitive impairment (CI), unhealthy weight status, and APOE genotypes in individuals of predominantly African descent aged 55 years and more. Genotyping of two single-nucleotide polymorphisms, rs7412 and rs429358, of the APOE gene was performed. Results: Among 310 individuals, the mean age was 75.64 years, the mean BMI was 25.94 kg/m2, and the prevalence of CI was 18.1%. Most subjects were ε3/ε3 carriers (49%), while ε2-carriers and ε4-carriers represented 14.5% and 36.5%, respectively. Older age, the presence of undernutrition, and APOE4 carriers were more frequently found in underweight vs. non-underweight individuals and in those with CI vs. those without CI. The adjusted odds ratios for prevalent CI were nearly four times higher for underweight individuals compared to obese individuals. Those carrying two ε4 alleles exhibited three times the odds of CI (OR = 3.31 (95% CI: 1.15–9.91), p = 0.026) compared to those with no ε4 alleles. Conclusions: In this cross-sectional study, being underweight and carrying the ApoE ε4 allele were independently associated with cognitive impairment. These findings suggest that monitoring weight changes and APOE genotypes in older adults may have clinical significance.
Open AccessRelationship Between Apolipoprotein E Genotypes, Unhealthy Weight Status, and Cognitive Impairment in Older Adults of Predominantly African Descent
Background: Apolipoprotein E4 (APOE4) represents a major genetic risk factor for Alzheimer’s disease. Objectives: We aimed to analyze the relationship between cognitive impairment (CI), unhealthy weight status, and APOE genotypes in individuals of predominantly African descent aged 55 years and more. Genotyping of two single-nucleotide polymorphisms, rs7412 and rs429358, of the APOE gene was performed. Results: Among 310 individuals, the mean age was 75.64 years, the mean BMI was 25.94 kg/m2, and the prevalence of CI was 18.1%. Most subjects were ε3/ε3 carriers (49%), while ε2-carriers and ε4-carriers represented 14.5% and 36.5%, respectively. Older age, the presence of undernutrition, and APOE4 carriers were more frequently found in underweight vs. non-underweight individuals and in those with CI vs. those without CI. The adjusted odds ratios for prevalent CI were nearly four times higher for underweight individuals compared to obese individuals. Those carrying two ε4 alleles exhibited three times the odds of CI (OR = 3.31 (95% CI: 1.15–9.91), p = 0.026) compared to those with no ε4 alleles. Conclusions: In this cross-sectional study, being underweight and carrying the ApoE ε4 allele were independently associated with cognitive impairment. These findings suggest that monitoring weight changes and APOE genotypes in older adults may have clinical significance.
- Open Access
- 5 May 2023
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1-9
Association between sexual behaviour and head and neck cancer in the French West Indies: a case-control study based on an Afro-Caribbean population
Worldwide, a significant proportion of head and neck cancers is attributed to the Human papillomavirus (HPV). It is imperative that we acquire a solid understanding of the natural history of this virus in head and neck squamous cell carcinoma (HNSCC) development. Our objective was to investigate the role of sexual behaviour in the occurrence of HNSCC in the French West Indies. Additionally, we evaluated the association of high risk of HPV (Hr-HPV) with sexual behaviour in risk of cancer. We conducted a population-based case-control study (145 cases and 405 controls). We used logistic regression models to estimate adjusted odds-ratios (OR), and their 95% confidence intervals (CI). Compared to persons who never practiced oral sex, those who practiced at least occasionally had a lower HNSCC risk. First sexual intercourse after the age of 18 year was associated with a 50% reduction of HNSCC risk, compared to those who began before 15 years. HNSCC risk was significantly reduced by 60% among persons who used condoms at least occasionally. The associations for ever condom use and oral sex were accentuated following the adjustment for high-risk HPV (Hr-HPV). Oral Hr-HPV was associated with several sexual behaviour variables among HNSCC cases. However, none of these variables were significantly associated with oral HPV infections in the population controls. First intercourse after 18 years, short time interval since last intercourse and ever condom use were inversely associated with HNSCC independently of oral Hr-HPV infection. Sources of transmission other than sexual contact and the interaction between HPV and HIV could also play a role in HNSCC etiology.
- 5 May 2023
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1-9
Open AccessAssociation between sexual behaviour and head and neck cancer in the French West Indies: a case-control study based on an Afro-Caribbean population
Worldwide, a significant proportion of head and neck cancers is attributed to the Human papillomavirus (HPV). It is imperative that we acquire a solid understanding of the natural history of this virus in head and neck squamous cell carcinoma (HNSCC) development. Our objective was to investigate the role of sexual behaviour in the occurrence of HNSCC in the French West Indies. Additionally, we evaluated the association of high risk of HPV (Hr-HPV) with sexual behaviour in risk of cancer. We conducted a population-based case-control study (145 cases and 405 controls). We used logistic regression models to estimate adjusted odds-ratios (OR), and their 95% confidence intervals (CI). Compared to persons who never practiced oral sex, those who practiced at least occasionally had a lower HNSCC risk. First sexual intercourse after the age of 18 year was associated with a 50% reduction of HNSCC risk, compared to those who began before 15 years. HNSCC risk was significantly reduced by 60% among persons who used condoms at least occasionally. The associations for ever condom use and oral sex were accentuated following the adjustment for high-risk HPV (Hr-HPV). Oral Hr-HPV was associated with several sexual behaviour variables among HNSCC cases. However, none of these variables were significantly associated with oral HPV infections in the population controls. First intercourse after 18 years, short time interval since last intercourse and ever condom use were inversely associated with HNSCC independently of oral Hr-HPV infection. Sources of transmission other than sexual contact and the interaction between HPV and HIV could also play a role in HNSCC etiology.
- Open Access
Consequences of In Utero Zika Virus Exposure and Adverse Pregnancy and Early Childhood Outcomes: A Prospective Cohort Study
We aimed to describe adverse pregnancy outcomes among women who had symptomatic, RT-PCR-confirmed ZIKV infection and early childhood outcomes among their infants. We enrolled pregnant women with symptomatic, RT-PCR-confirmed ZIKV infection in a prospective cohort study, and their infants in a prospective pediatric cohort study. We defined adverse pregnancy and early childhood outcomes based on selected neurologic, ophthalmologic, auditory, musculoskeletal, and anthropometric abnormalities. We used RT-PCR and serologic tests to determine the ZIKV infection status of the child. Between 10 March and 24 November 2016, we enrolled 546 pregnant women with RT-PCR-confirmed ZIKV infection. The overall risk of adverse pregnancy and early childhood outcomes possibly related to in utero ZIKV exposure was 15.7% (95% CI: 12.8–19.0), distributed as follows: 3.6% (95% CI: 2.3–5.6) severe sequelae or fatality; 2.7% (95% CI: 1.6–4.5) major abnormalities; 9.4% (95% CI:7.1–12.2) mild abnormalities. The risk of severe sequelae or fatality was higher when ZIKV infection occurred during the first trimester (7.0%), compared to the second (2.7%) or third trimester (1.4%) (p = 0.02). Among the infants for whom ZIKV infection status could be determined, the vertical transmission rate was 3.0% (5/167) (95% CI: 1.1–7.2). Among pregnant women with symptomatic, RT-PCR-confirmed ZIKV infection, severe or major pregnancy or early childhood outcomes were present in 6.3% of fetuses and infants. Severe outcomes occurred more frequently in fetuses and infants whose mothers had been infected in the first trimester.
Open AccessConsequences of In Utero Zika Virus Exposure and Adverse Pregnancy and Early Childhood Outcomes: A Prospective Cohort Study
We aimed to describe adverse pregnancy outcomes among women who had symptomatic, RT-PCR-confirmed ZIKV infection and early childhood outcomes among their infants. We enrolled pregnant women with symptomatic, RT-PCR-confirmed ZIKV infection in a prospective cohort study, and their infants in a prospective pediatric cohort study. We defined adverse pregnancy and early childhood outcomes based on selected neurologic, ophthalmologic, auditory, musculoskeletal, and anthropometric abnormalities. We used RT-PCR and serologic tests to determine the ZIKV infection status of the child. Between 10 March and 24 November 2016, we enrolled 546 pregnant women with RT-PCR-confirmed ZIKV infection. The overall risk of adverse pregnancy and early childhood outcomes possibly related to in utero ZIKV exposure was 15.7% (95% CI: 12.8–19.0), distributed as follows: 3.6% (95% CI: 2.3–5.6) severe sequelae or fatality; 2.7% (95% CI: 1.6–4.5) major abnormalities; 9.4% (95% CI:7.1–12.2) mild abnormalities. The risk of severe sequelae or fatality was higher when ZIKV infection occurred during the first trimester (7.0%), compared to the second (2.7%) or third trimester (1.4%) (p = 0.02). Among the infants for whom ZIKV infection status could be determined, the vertical transmission rate was 3.0% (5/167) (95% CI: 1.1–7.2). Among pregnant women with symptomatic, RT-PCR-confirmed ZIKV infection, severe or major pregnancy or early childhood outcomes were present in 6.3% of fetuses and infants. Severe outcomes occurred more frequently in fetuses and infants whose mothers had been infected in the first trimester.
- Open Access
- 23 September 2021
- Published by Ubiquity Press, Ltd. in Open Journal of Bioresources
- Vol. 8
Karubiotec™ the Human Biobank of Guadeloupe (French West Indies): A Driver Towards Caribbean Health Research
Karubiotec™ is a mono-site Biological Resources Center (BRC) and the only human biobank of Guadeloupe. It is an infrastructure of the University Hospital of Guadeloupe, which governed it. Located inside the hospital it is equipped with a molecular biology platform that allows all the processes from reception to preparation, storage and transfer of biological resources and their associated clinical data. These data are either part of specific research projects or of the BRC’s own research programs. After studying requests, Karubiotec™ can provide samples from blood (serum, plasma, cells, DNA, RNA), secretions and tissues for most common diseases found in the Caribbean [1], in respect of ethics requirements according to the proposed use. Paraffin blocks and slides from pathology units are also collected for some cancer sites for research reuse.
- 23 September 2021
- Published by Ubiquity Press, Ltd. in Open Journal of Bioresources
- Vol. 8
Open AccessKarubiotec™ the Human Biobank of Guadeloupe (French West Indies): A Driver Towards Caribbean Health Research
Karubiotec™ is a mono-site Biological Resources Center (BRC) and the only human biobank of Guadeloupe. It is an infrastructure of the University Hospital of Guadeloupe, which governed it. Located inside the hospital it is equipped with a molecular biology platform that allows all the processes from reception to preparation, storage and transfer of biological resources and their associated clinical data. These data are either part of specific research projects or of the BRC’s own research programs. After studying requests, Karubiotec™ can provide samples from blood (serum, plasma, cells, DNA, RNA), secretions and tissues for most common diseases found in the Caribbean [1], in respect of ethics requirements according to the proposed use. Paraffin blocks and slides from pathology units are also collected for some cancer sites for research reuse.
- Open Access
- 3 March 2021
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15 (3) , e0009048
Reassessment of the risk of birth defects due to Zika virus in Guadeloupe, 2016
In the French Territories in the Americas (FTA), the risk of birth defects possibly associated with Zika virus (ZIKV) infection was 7.0% (95%CI: 5.0 to 9.5) among foetuses/infants of 546 women with symptomatic RT-PCR confirmed ZIKV infection during pregnancy. Many of these defects were isolated measurement-based microcephaly (i.e. without any detected brain or clinical abnormalities) or mild neurological conditions. We wanted to estimate the proportion of such minor findings among live births of women who were pregnant in the same region during the outbreak period but who were not infected with ZIKV. In Guadeloupe, pregnant women were recruited at the time of delivery and tested for ZIKV infection. The outcomes of live born infants of ZIKV non-infected women were compared to those of ZIKV-exposed live born infants in Guadeloupe, extracted from the FTA prospective cohort. Of 490 live born infants without exposure to ZIKV, 42 infants (8.6%, 95%CI: 6.2–11.4) had mild abnormalities that have been described as ‘potentially linked to ZIKV infection’; all but one of these was isolated measurement-based microcephaly. Among the 241 live born infants with ZIKV exposure, the proportion of such abnormalities, using the same definition, was similar (6.6%, 95%CI: 3.8–10.6). Isolated anthropometric abnormalities and mild neurological conditions were as prevalent among infants with and without in-utero ZIKV exposure. If such abnormalities had not been considered as ‘potentially linked to ZIKV’ in the original prospective cohort in Guadeloupe, the overall estimate of the risk of birth defects considered due to the virus would have been significantly lower, at approximately 1.6% (95% CI: 0.4–4.1). ClinicalTrials.gov (NCT02916732) Microcephaly defined using growth charts occurs naturally in some healthy infants. Nonetheless, in many recent Zika virus studies, such measurement-based microcephaly and other common mild abnormalities have been automatically attributed to viral exposure during pregnancy. For example, in 2016 in Guadeloupe, we did a cohort study and estimated that the risk of Zika virus related birth defects was 7%. However, most of the ‘abnormal’ live born infants that contributed to this risk estimate were considered healthy by pediatricians, but were found to have measurement-based microcephaly during data analysis. In the current study, we did a cross-sectional evaluation of infants live born in 2016 in Guadeloupe, but whose mothers were not infected with Zika virus during pregnancy. We found that Zika virus unexposed live born infants had similar proportions of measurement-based microcephaly and mild neurological abnormalities as exposed live born infants. If only severe and uncommon birth defects were considered linked to Zika virus in our original cohort study, our risk estimate would have been significantly lower. This research shows that it is important to consider baseline risks and control comparisons when establishing key parameters for emerging diseases, such as Zika virus.
- 3 March 2021
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 15 (3) , e0009048
Open AccessReassessment of the risk of birth defects due to Zika virus in Guadeloupe, 2016
In the French Territories in the Americas (FTA), the risk of birth defects possibly associated with Zika virus (ZIKV) infection was 7.0% (95%CI: 5.0 to 9.5) among foetuses/infants of 546 women with symptomatic RT-PCR confirmed ZIKV infection during pregnancy. Many of these defects were isolated measurement-based microcephaly (i.e. without any detected brain or clinical abnormalities) or mild neurological conditions. We wanted to estimate the proportion of such minor findings among live births of women who were pregnant in the same region during the outbreak period but who were not infected with ZIKV. In Guadeloupe, pregnant women were recruited at the time of delivery and tested for ZIKV infection. The outcomes of live born infants of ZIKV non-infected women were compared to those of ZIKV-exposed live born infants in Guadeloupe, extracted from the FTA prospective cohort. Of 490 live born infants without exposure to ZIKV, 42 infants (8.6%, 95%CI: 6.2–11.4) had mild abnormalities that have been described as ‘potentially linked to ZIKV infection’; all but one of these was isolated measurement-based microcephaly. Among the 241 live born infants with ZIKV exposure, the proportion of such abnormalities, using the same definition, was similar (6.6%, 95%CI: 3.8–10.6). Isolated anthropometric abnormalities and mild neurological conditions were as prevalent among infants with and without in-utero ZIKV exposure. If such abnormalities had not been considered as ‘potentially linked to ZIKV’ in the original prospective cohort in Guadeloupe, the overall estimate of the risk of birth defects considered due to the virus would have been significantly lower, at approximately 1.6% (95% CI: 0.4–4.1). ClinicalTrials.gov (NCT02916732) Microcephaly defined using growth charts occurs naturally in some healthy infants. Nonetheless, in many recent Zika virus studies, such measurement-based microcephaly and other common mild abnormalities have been automatically attributed to viral exposure during pregnancy. For example, in 2016 in Guadeloupe, we did a cohort study and estimated that the risk of Zika virus related birth defects was 7%. However, most of the ‘abnormal’ live born infants that contributed to this risk estimate were considered healthy by pediatricians, but were found to have measurement-based microcephaly during data analysis. In the current study, we did a cross-sectional evaluation of infants live born in 2016 in Guadeloupe, but whose mothers were not infected with Zika virus during pregnancy. We found that Zika virus unexposed live born infants had similar proportions of measurement-based microcephaly and mild neurological abnormalities as exposed live born infants. If only severe and uncommon birth defects were considered linked to Zika virus in our original cohort study, our risk estimate would have been significantly lower. This research shows that it is important to consider baseline risks and control comparisons when establishing key parameters for emerging diseases, such as Zika virus.
- 1 November 2019
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 57 (11)
Kinetics of Anti-Zika Virus Antibodies after Acute Infection in Pregnant Women
The kinetics of anti-Zika virus (ZIKV) antibodies after acute ZIKV infection is not well known (1,2), especially in areas where different flaviviruses circulate (3).…
- 1 November 2019
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 57 (11)
Kinetics of Anti-Zika Virus Antibodies after Acute Infection in Pregnant Women
The kinetics of anti-Zika virus (ZIKV) antibodies after acute ZIKV infection is not well known (1,2), especially in areas where different flaviviruses circulate (3).…
- Open Access
- 23 October 2019
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 6 (Supplement) , S47
1874. Comparison of the Risk of Birth Defects in Live Births From Pregnant Women Infected and Not Infected by Zika Virus in Guadeloupe, 2016–2017
In the French Territories in the Americas (FTA), the risk of birth defects possibly associated with Zika virus (ZIKV) infection was estimated at 7% among fetuses/infants in a cohort of 546 women who developed a symptomatic RT-PCR confirmed ZIKV infection during pregnancy (NEJM 2018;378:985–94). There was no concomitant prospective cohort of pregnant women without ZIKV infection to use as a control group. In Guadeloupe, one of the 3 FTAs that participated in the FTA cohort study, pregnant women were recruited at the time of delivery and tested for ZIKV infection. Women who had a confirmed negative IgG serology test for ZIKV at delivery and no other positive ZIKV test during pregnancy were considered to be ZIKV noninfected. Information on the course of the pregnancy was collected retrospectively and outcomes of live born infants of ZIKV noninfected women were analyzed, using the same definition criteria as those used for the FTA cohort study. Pregnancy outcomes were compared with those of the 241 ZIKV-exposed live born infants in Guadeloupe, extracted from the FTA cohort. Of the 490 live born infants without in-utero exposure to ZIKV, 42 infants (8.6%) had neurological abnormalities that were described as “potentially linked to ZIKV infection”; all but one of these were microcephaly without any other brain or clinical abnormalities. The proportion of such abnormalities was not statistically different from that observed in the 241 live born infants with ZIKV exposure (6.6%, P = 0.36). When re-considering the combined 8 fetuses and 241 infants of women with confirmed ZIKV infection in Guadeloupe from the FTA cohort, only two (0.8%) live born infants and three (1.2%) medically aborted fetuses had birth defects that could still be linked to ZIKV infection. Isolated anthropometric and other mild neurological abnormalities had the same prevalence among live born infants with and without in utero ZIKV exposure. The high prevalence of isolated microcephaly among ZIKV noninfected women in our study population suggests that the sensitive definition for microcephaly, using a −2 SD cut-off with international growth curves, may lead to an overestimate of the rate of neurological complications of ZIKV infection during pregnancy. All Authors: No reported Disclosures.
- 23 October 2019
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 6 (Supplement) , S47
Open Access1874. Comparison of the Risk of Birth Defects in Live Births From Pregnant Women Infected and Not Infected by Zika Virus in Guadeloupe, 2016–2017
In the French Territories in the Americas (FTA), the risk of birth defects possibly associated with Zika virus (ZIKV) infection was estimated at 7% among fetuses/infants in a cohort of 546 women who developed a symptomatic RT-PCR confirmed ZIKV infection during pregnancy (NEJM 2018;378:985–94). There was no concomitant prospective cohort of pregnant women without ZIKV infection to use as a control group. In Guadeloupe, one of the 3 FTAs that participated in the FTA cohort study, pregnant women were recruited at the time of delivery and tested for ZIKV infection. Women who had a confirmed negative IgG serology test for ZIKV at delivery and no other positive ZIKV test during pregnancy were considered to be ZIKV noninfected. Information on the course of the pregnancy was collected retrospectively and outcomes of live born infants of ZIKV noninfected women were analyzed, using the same definition criteria as those used for the FTA cohort study. Pregnancy outcomes were compared with those of the 241 ZIKV-exposed live born infants in Guadeloupe, extracted from the FTA cohort. Of the 490 live born infants without in-utero exposure to ZIKV, 42 infants (8.6%) had neurological abnormalities that were described as “potentially linked to ZIKV infection”; all but one of these were microcephaly without any other brain or clinical abnormalities. The proportion of such abnormalities was not statistically different from that observed in the 241 live born infants with ZIKV exposure (6.6%, P = 0.36). When re-considering the combined 8 fetuses and 241 infants of women with confirmed ZIKV infection in Guadeloupe from the FTA cohort, only two (0.8%) live born infants and three (1.2%) medically aborted fetuses had birth defects that could still be linked to ZIKV infection. Isolated anthropometric and other mild neurological abnormalities had the same prevalence among live born infants with and without in utero ZIKV exposure. The high prevalence of isolated microcephaly among ZIKV noninfected women in our study population suggests that the sensitive definition for microcephaly, using a −2 SD cut-off with international growth curves, may lead to an overestimate of the rate of neurological complications of ZIKV infection during pregnancy. All Authors: No reported Disclosures.